The landscape of immune checkpoint inhibitor therapy in advanced lung cancerChengdi Wang, Yalun Li, Jingwei Li et al.|BMC Cancer|2021Cited by 25
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trialFahong Li, Jiming Zhang, Xun Qi et al.|Journal of Hepatology|2024Cited by 18